Accueil > Publications > Recherche par années > Années 2010 > 2017

Poupard, N., Badarou, P., Fasani, F., Groult, H., Bridiau, N., Sannier, F., Bordenave-Juchereau, S., Kieda, C., Piot, J.-M., Grillon, C., Fruitier-Arnaudin, I. and Maugard, T.

Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells : Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic Agent

Marine Drugs (2017) 15 (5) 134

par Frapart - publié le

Abstract :

Heparanase is overexpressed by tumor cells and degrades the extracellular matrix proteoglycans through cleavage of heparan sulfates (HS), allowing pro-angiogenic factor release and thus playing a key role in tumor angiogenesis and metastasis. Here we propose new HS analogs as potent heparanase inhibitors : Heparin as a positive control, Dextran Sulfate, λ-Carrageenan, and modified forms of them obtained by depolymerization associated to glycol splitting (RD-GS). After heparanase activity assessment, 11 kDa RD-GS-λ-Carrageenan emerged as the most effective heparanase inhibitor with an IC(50) of 7.32 ng/mL compared to 10.7 ng/mL for the 16 kDa unfractionated heparin. The fractionated polysaccharides were then tested in a heparanase-rich medium-based in vitro model, mimicking tumor microenvironment, to determine their effect on microvascular endothelial cells (HSkMEC) angiogenesis. As a preliminary study, we identified that under hypoxic and nutrient poor conditions, MCF-7 cancer cells released much more mature heparanase in their supernatant than in normal conditions. Then a Matrigel(TM) assay using HSkMEC cultured under hypoxic conditions in the presence (or not) of this heparanase-rich supernatant was realized. Adding heparanase-rich media strongly enhanced angiogenic network formation with a production of twice more pseudo-vessels than with the control. When sulfated polysaccharides were tested in this angiogenesis assay, RD-GS-λ-Carrageenan was identified as a promising anti-angiogenic agent.

Voir en ligne : 10.3390/md15050134